Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. [electronic resource]
Producer: 19950525Description: 1418-24 p. digitalISSN:- 0028-4793
- Adult
- Aged
- Cerebrovascular Disorders -- etiology
- Cost-Benefit Analysis
- Costs and Cost Analysis
- Drug Administration Schedule
- Humans
- Life Expectancy
- Middle Aged
- Myocardial Infarction -- complications
- Prospective Studies
- Quality of Life
- Risk
- Streptokinase -- economics
- Thrombolytic Therapy -- economics
- Tissue Plasminogen Activator -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.